skip to Main Content
Ohio Committee drops support for approving marijuana to treat autism, anxiety

A committee of experts has rescinded its recommendation to approve medical marijuana to treat autism and anxiety in Ohio.

The expert review committee of the Ohio Medical Marijuana Control Program had voted last fall to recommend that the State Medical Board of Ohio approve marijuana to treat those conditions, but it reversed course after hearing from a panel of experts Wednesday.

Two experts testified in favor of marijuana’s use, and four experts against it. In Ohio, marijuana is approved to treat 21 medical conditions, including chronic pain and post-traumatic stress disorder.

The committee decided that research on the use of marijuana to treat autism and anxiety is inconclusive.

“At this point, approval seems premature,” said medical board President Michael Schottenstein, who is also a member of the review committee. “There should be a consensus, and it’s clear that we don’t have that.”

Committee member Robert Giacalone also opposed the recommendation. “There is, at best, anecdotal evidence on the other side,” he said.

Once a condition is on the list of 21 qualifying conditions, it cannot be removed, Schottenstein said. The board can add the condition later if more compelling evidence emerges, he said. [Read more at The Columbus Dispatch]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business —  legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

More Categories

Back To Top
×Close search
Search